Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRolls-Royce Regulatory News (RR.)

Share Price Information for Rolls-Royce (RR.)

Share Price is delayed by 15 minutes
Get Live Data
1,432.00    12.80 (0.90%)
Bid:
1,431.80
Ask:
1,432.40
Spread: 0.60 (0.042%)
Market Cap: £118.68b
RR. Live PriceLast checked at - London Stock Exchange

Intraday Rolls-Royce Share Chart

Director/PDMR Shareholding

1 Dec 2025 17:00

RNS Number : 7502J
Rolls-Royce Holdings plc
01 December 2025
 

1 December 2025

Rolls-Royce Holdings plc

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Rolls-Royce Holdings plc (the Company) announces that the following person(s) discharging managerial responsibilities transacted in ordinary shares of 20p each in the Company (Shares) under the Rolls-Royce Incentive Plan, as set out in the remuneration policy approved by shareholders at the 2025 AGM.

Vesting of awards

The following Shares vested on 28 November 2025 in relation to awards made on 28 November 2023 following a percentage of base salary being deferred into Shares for two years under the Rolls-Royce Incentive Plan.

PDMR

Shares vested

Shares sold to cover statutory withholding liabilities

Shares retained

Tufan Erginbilgic

13,010

6,128

6,882

Helen McCabe

5,029

2,369

2,660

 

The salary deferred Shares above includes accumulated dividends during the vesting periods which were reinvested in Shares on 28 November 2025 based on the average mid-market closing price on the three days leading up to and including the relevant dividend record dates.

PDMR

Share price

Number of shares

Tufan Erginbilgic

£7.182

107

£10.7883

54

Helen McCabe

£7.182

41

£10.7883

20

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Tufan Erginbilgic

2

Reason for the notification

 

a)

Position/status

Chief Executive

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Rolls-Royce Holdings plc

b)

LEI

213800EC7997ZBLZJH69

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

 

Ordinary Shares of 20p each

 

GB00B63H8491

Transaction 1

b)

 

Nature of the transaction

Vest of Shares received in lieu of a percentage of base salary, including accumulated dividends reinvested in Shares

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

 

 

Price(s)

 

Volume(s)

Nil

12,849

£7.182

107

£10.7883

54

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

13,010

 

£1,351.04

e)

Date of the transaction

28 November 2025

f)

Place of the transaction

Outside a trading venue

Transaction 2

b)

Nature of the transaction

Sale of Shares to cover statutory withholding liabilities

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

 

Volume(s)

£10.645

6,128

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

6,128

 

£65,232,56

e)

Date of the transaction

28 November 2025

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Helen McCabe

2

Reason for the notification

 

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Rolls-Royce Holdings plc

b)

LEI

213800EC7997ZBLZJH69

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

 

Ordinary Shares of 20p each

 

GB00B63H8491

Transaction 1

b)

 

Nature of the transaction

Vest of Shares received in lieu of a percentage of base salary, including accumulated dividends reinvested in Shares

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

 

Price(s)

 

Volume(s)

Nil

4,968

£7.182

41

£10.7883

20

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

5,029

 

£510.23

e)

Date of the transaction

28 November 2025

f)

Place of the transaction

Outside a trading venue

Transaction 2

b)

Nature of the transaction

Sale of Shares to cover statutory withholding liabilities

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

 

Volume(s)

£10.645

2,369

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

2,369

 

£25,218.01

e)

Date of the transaction

28 November 2025

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

Name of officer of issuer responsible for making notification: Matthew Conacher

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUBDDCSGDGUB
Date   Source Headline
4th Aug 202311:51 amRNSHolding(s) in Company
3rd Aug 20237:00 amRNS2023 Half Year Results
2nd Aug 20237:00 amRNSDirectorate Change
31st Jul 20239:30 amRNSDirector/PDMR Shareholding
26th Jul 20237:00 amRNSTrading Update
20th Jul 20239:00 amRNSDirectorate Change
10th Jul 20233:30 pmRNSDirector/PDMR Shareholding
3rd Jul 20239:32 amRNSTotal Voting Rights
28th Jun 20233:30 pmRNSDirector/PDMR Shareholding
27th Jun 202312:00 pmRNSAdmission of Shares
8th Jun 20232:00 pmRNSDirector/PDMR Shareholding
30th May 202312:00 pmRNSDirector/PDMR Shareholding
19th May 202312:00 pmRNSDirector/PDMR Shareholding
11th May 20232:07 pmRNSResult of AGM
11th May 20239:14 amRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSAGM Statement and Trading Update
10th May 20234:00 pmRNSDirectorate change & withdrawal of AGM resolution
28th Apr 20233:44 pmRNSDirector/PDMR Shareholding
14th Apr 20239:30 amRNSDirector/PDMR Shareholding
11th Apr 20231:00 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSDirectorate Change
29th Mar 20239:34 amRNSDirector/PDMR Shareholding
21st Mar 20233:03 pmRNSDirector/PDMR Shareholding
17th Mar 20233:00 pmRNSDirector/PDMR Shareholding
10th Mar 20232:35 pmRNSDirector/PDMR Shareholding
8th Mar 20233:39 pmRNSDirector/PDMR Shareholding
2nd Mar 20239:00 amRNSAnnual Report 2022 and Annual General Meeting 2023
1st Mar 20235:05 pmRNSHolding(s) in Company
28th Feb 20234:17 pmRNSDirector/PDMR Shareholding
24th Feb 202312:00 pmRNSDirector/PDMR Shareholding
23rd Feb 20237:00 amRNS2022 Full Year Results
10th Feb 20239:09 amRNSDirector Declaration
9th Feb 20239:30 amRNSDirector/PDMR Shareholding
9th Feb 20237:00 amRNSDirectorate Change
31st Jan 20239:30 amRNSDirector/PDMR Shareholding
11th Jan 20233:50 pmRNSDirector/PDMR Shareholding
22nd Dec 202211:05 amRNSDirector/PDMR Shareholding
21st Dec 20229:37 amRNSDirectorate Change
8th Dec 20222:37 pmRNSDirector/PDMR Shareholding
5th Dec 20224:04 pmRNSDirector/PDMR Shareholding
29th Nov 20229:30 amRNSDirector/PDMR Shareholding
18th Nov 202210:07 amRNSHolding(s) in Company
14th Nov 202210:00 amRNSHolding(s) in Company
10th Nov 20229:15 amRNSHolding(s) in Company
9th Nov 20222:40 pmRNSDirector/PDMR Shareholding
3rd Nov 20227:00 amRNSTrading Statement
31st Oct 20229:30 amRNSDirector/PDMR Shareholding
18th Oct 20222:45 pmRNSDirector Declaration
13th Oct 20223:15 pmRNSHolding(s) in Company
10th Oct 20225:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.